How to Talk About High Drug Costs in a Time of Economic Insecurity

A Reference Guide for Lawmakers

Health care and the cost of prescription drugs are top issues for voters across the country. AAM developed a resource for effective communications around the concern for the rising cost of prescription drugs during COVID-19, “How to Talk About High Drug Costs in a Time of Economic Insecurity." This primer outlines how anticompetitive tactics limit patient access to FDA-approved generics and biosimilars, and how competition helps reduce drug prices.

View Guide

View 2020 Access & Savings Report